New closed-loop insulin systems.
Diabetologia
; 64(5): 1007-1015, 2021 05.
Article
em En
| MEDLINE
| ID: mdl-33550442
ABSTRACT
Advances in diabetes technologies have enabled the development of automated closed-loop insulin delivery systems. Several hybrid closed-loop systems have been commercialised, reflecting rapid transition of this evolving technology from research into clinical practice, where it is gradually transforming the management of type 1 diabetes in children and adults. In this review we consider the supporting evidence in terms of glucose control and quality of life for presently available closed-loop systems and those in development, including dual-hormone closed-loop systems. We also comment on alternative 'do-it-yourself' closed-loop systems. We remark on issues associated with clinical adoption of these approaches, including training provision, and consider limitations of presently available closed-loop systems and areas for future enhancements to further improve outcomes and reduce the burden of diabetes management.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Sistemas de Infusão de Insulina
/
Pâncreas Artificial
/
Insulina
Limite:
Adult
/
Child
/
Humans
Idioma:
En
Revista:
Diabetologia
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Reino Unido